Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
Employees
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
Employees

ASND Key Statistics

Market cap
15.61B
Market cap15.61B
Price-Earnings ratio
27.01
Price-Earnings ratio27.01
Dividend yield
Dividend yield
Average volume
477.00K
Average volume477.00K
High today
High today
Low today
Low today
Open price
$250.00
Open price$250.00
Volume
0.00
Volume0.00
52 Week high
$282.15
52 Week high$282.15
52 Week low
$171.90
52 Week low$171.90

Stock Snapshot

As of today, Ascendis Pharma A/S(ASND) shares are valued at $251.07. The company's market cap stands at 15.61B, with a P/E ratio of 27.01.

Ascendis Pharma A/S(ASND) stock opened on 2026-07-31 at $250.00. The price climbed to — and dipped to —.

The Ascendis Pharma A/S(ASND)'s current trading volume is 0, compared to an average daily volume of 477K.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $171.90 at its lowest and $282.15 at its peak.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $171.90 at its lowest and $282.15 at its peak.

ASND News

Simply Wall St 2d
Ascendis Pharma Could Be 17% Below Fair Value Following Its TransCon Narrative

Ascendis Pharma (NasdaqGS:ASND) has drawn fresh investor attention after recent trading left the stock around $254.44, with short term returns mixed over the pa...

Ascendis Pharma Could Be 17% Below Fair Value Following Its TransCon Narrative
TipRanks 3d
Ascendis Pharma Expands Yorvipath Into Adolescents, Raising Long-Term Growth Hopes

Ascendis Pharma A/S (ASND) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more con...

Analyst ratings

100%

of 20 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.